Literature DB >> 2589001

Cyanide release from sodium nitroprusside during coronary bypass in hypothermia.

P Lundquist1, H Rosling, H Tydén.   

Abstract

Erythrocyte cyanide levels were determined by a sensitive fluorimetric method on four occasions during coronary bypass in hypothermia in 18 consecutive patients treated with sodium nitroprusside (SNP) with an infusion rate less than 1 microgram x kg-1 x min-1. Every second patient received the cyanide antidote thiosulphate simultaneously with the SNP-infusion. At normal body temperature, as well as during hypothermia in cases receiving thiosulphate, the cyanide levels rose slowly but significantly with the infusion rate. Higher erythrocyte cyanide levels in relation to the infusion rates, up to 8.0 mumol/l, were found during hypothermia in two of the cases not receiving thiosulphate. We conclude that SNP is broken down to cyanide even under hypothermia and that low body temperature may impair the conversion of cyanide to thiocyanate, probably by affecting the metabolic pathways providing the sulphur substrate. This effect may add to other factors decreasing sulphur availability in critically ill patients, and simultaneous administration of thiosulphate is therefore recommended to ensure a safe SNP treatment during and after coronary bypass operations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589001     DOI: 10.1111/j.1399-6576.1989.tb02992.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

1.  Cyanide poisoning in the post-transplantation patient-a cautionary tale.

Authors:  Catherine Quinlan; Denis Gill; Mary Waldron; Atif Awan
Journal:  Pediatr Nephrol       Date:  2008-08-07       Impact factor: 3.714

2.  Comparison Between Two Pharmacologic Strategies to Alleviate Rewarming Shock: Vasodilation vs. Inodilation.

Authors:  Brage Håheim; Timofei Kondratiev; Erik Sveberg Dietrichs; Torkjel Tveita
Journal:  Front Med (Lausanne)       Date:  2020-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.